XTX-201

N/A

Report date: 2024/05/15 15:12:47

Base Information

Drug NameXTX-201
Drug Alias NameXTX-201XTX201
ClassificationBiologics
Mechanisms of ActionAntibody-dependent cell-mediated cytotoxicity (ADCC) effectsImmunostimulantsInterleukin-2 agonists
TargetsInterleukin-2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesXilio Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesXilio Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A